Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Pine Care Group Limited (1989.HK)
Tsz Wan Shan, HK
Operating within Hong Kong, Pine Care Group Limited specializes in delivering extensive care services for the elderly. Its core offerings include residential placements, professional nursing and personal support, nutritional guidance, medical assistance, and programs addressing psychological and social well-being, all tailored through individualized care strategies. Beyond these direct services, the company also engages in property investment, management, and maintenance, in addition to providing rehabilitation and physiotherapy, broader healthcare services, and the sale of products relevant to elder care. Founded in 1989, Pine Care Group manages a network comprising 11 senior care and assisted living facilities.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.54% | -5.01% | +5.63% | +91.67% | +91.67% | +91.67% | +91.67% | +91.67% | +15,900.00% | +21,547.06% | +21,547.06% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%-0.9% Q3'23: +16.2% (vs Q3'21)
-
EPS growth Medical - Care Facilities: +19.2%-34.5% Q3'23: -1,103.8% (vs Q3'21)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-2.4% Q3'23: +8.6% (vs Q3'21)
-
EBIT margin Medical - Care Facilities: +11.3%-5.1% Q3'23: +0.3% (vs Q3'21)
-
ROIC Medical - Care Facilities: +6.8%-1.3% Q3'23: +0.2% (vs Q3'21)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q3'23: 0.0% (vs Q3'21)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×15.05× Q3'23: 4.80× (vs Q3'21)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|
| Revenue |
265.21M
est.
|
6.28B
6.28B – 6.28B
+2,268.8% YoY
|
| EBITDA |
61.65M
est.
|
1.46B
1.46B – 1.46B
+2,268.8% YoY
|
| EBIT |
11.05M
est.
|
261.86M
261.86M – 261.86M
+2,268.8% YoY
|
| Net Income |
—
est.
|
2.50B
2.50B – 2.50B
|
| SGA |
16.66M
est.
|
394.76M
394.76M – 394.76M
+2,268.8% YoY
|
| EPS |
—
est.
|
2.77
2.77 – 2.77
|
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | JPMorgan BetaBuilders Emerging Markets Equity ETF BBEM | 0.00% | 26.3K | 0.15% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hong Zeng | GM & Executive Director | 5M | female |
| Yip Keung Chan | Chief Executive Officer & Executive Director | 738.0K | male |
| Lai King Chu | Group Head of Human Resources | 50.0K | female |
| Jinghui Peng | Employee Representative Executive Director | — | male |
| Jun Wang | Deputy General Manager | — | male |
| Boren Yang | Head of the Marketing Center | — | male |
| Pui Lam | Marketing & Business Development Director | — | female |
| Qinyuan Li | Deputy GM & Chief Engineer | — | male |
| Sau In Kwan | Joint Company Secretary | — | female |
| Shaobo Yang | Head of the Quality Control Department | — | male |
| Sze Hung Lo | Chief Financial Officer & Company Secretary | — | male |
| Yangqing Zeng | Deputy GM & Joint Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1989.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
